Immunomodulatory effects of selected chemotherapeutics
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
Chemotherapeutics are still regarded as a mainstay of antitumor strategies.A number of observations indicate that these agents might be used at low doseswith the same or even better efficacy than the high-dose chemotherapy. The efficacy of the low-dose chemotherapy might be at least partly explained by theregulation of the antitumor immune response. These immunomodulatory effects might be further potentiated by combinations with selected biological response modifiers, such as recombinant cytokines (lL-2, TNF, IL-12). The effectiveness of such combinations has already proved encouraging in pre-clinicalmodels.
Biotechnologia, vol.54, 3 (2001)-.
0860-7796 ; oai:rcin.org.pl:138860 ; IChB B-50
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
2 paź 2020
14 wrz 2020
199
https://rcin.org.pl./publication/174149
Nazwa wydania | Data |
---|---|
Immunomodulujące działanie wybranych chemioterapeutyków przeciwnowotworowych | 2 paź 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan